These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39136468)

  • 1.
    Kreutzfeld O; Orena S; Okitwi M; Tumwebaze PK; Byaruhanga O; Katairo T; Conrad MD; Legac J; Garg S; Crudale R; Aydemir O; Giesbrecht D; Nsobya SL; Blasco B; Duffey M; Rouillier M; Bailey JA; Cooper RA; Rosenthal PJ
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0046624. PubMed ID: 39136468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline.
    Kreutzfeld O; Tumwebaze PK; Okitwi M; Orena S; Byaruhanga O; Katairo T; Conrad MD; Rasmussen SA; Legac J; Aydemir O; Giesbrecht D; Forte B; Campbell P; Smith A; Kano H; Nsobya SL; Blasco B; Duffey M; Bailey JA; Cooper RA; Rosenthal PJ
    Microbiol Spectr; 2023 Jun; 11(3):e0523622. PubMed ID: 37158739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low polymorphisms in pfact, pfugt and pfcarl genes in African Plasmodium falciparum isolates and absence of association with susceptibility to common anti-malarial drugs.
    Foguim FT; Robert MG; Gueye MW; Gendrot M; Diawara S; Mosnier J; Amalvict R; Benoit N; Bercion R; Fall B; Madamet M; Pradines B;
    Malar J; 2019 Aug; 18(1):293. PubMed ID: 31455301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between Varied Susceptibilities to PfATP4 Inhibitors and Genotypes in Ugandan Plasmodium falciparum Isolates.
    Kreutzfeld O; Rasmussen SA; Ramanathan AA; Tumwebaze PK; Byaruhanga O; Katairo T; Asua V; Okitwi M; Orena S; Legac J; Conrad MD; Nsobya SL; Aydemir O; Bailey J; Duffey M; Bayles BR; Vaidya AB; Cooper RA; Rosenthal PJ
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0077121. PubMed ID: 34339273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates.
    Foguim FT; Bogreau H; Gendrot M; Mosnier J; Fonta I; Benoit N; Amalvict R; Madamet M; Wein S; Pradines B;
    Malar J; 2020 Jun; 19(1):201. PubMed ID: 32503540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.
    Aguiar AC; Pereira DB; Amaral NS; De Marco L; Krettli AU
    Malar J; 2014 Feb; 13():73. PubMed ID: 24581308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing Antimalarial Drug Sensitivities in Uganda.
    Rasmussen SA; Ceja FG; Conrad MD; Tumwebaze PK; Byaruhanga O; Katairo T; Nsobya SL; Rosenthal PJ; Cooper RA
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome Inhibitors.
    Garg S; Kreutzfeld O; Chelebieva S; Tumwebaze PK; Byaruhanga O; Okitwi M; Orena S; Katairo T; Nsobya SL; Conrad MD; Aydemir O; Legac J; Gould AE; Bayles BR; Bailey JA; Duffey M; Lin G; Kirkman LA; Cooper RA; Rosenthal PJ
    Antimicrob Agents Chemother; 2022 Oct; 66(10):e0081722. PubMed ID: 36094216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Susceptibility to Dihydrofolate Reductase Inhibitors Associated With Genetic Polymorphisms in Ugandan Plasmodium falciparum Isolates.
    Kreutzfeld O; Tumwebaze PK; Byaruhanga O; Katairo T; Okitwi M; Orena S; Rasmussen SA; Legac J; Conrad MD; Nsobya SL; Aydemir O; Bailey JA; Duffey M; Cooper RA; Rosenthal PJ
    J Infect Dis; 2022 Feb; 225(4):696-704. PubMed ID: 34460932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment
    Yipsirimetee A; Chiewpoo P; Tripura R; Lek D; Day NPJ; Dondorp AM; Pukrittayakamee S; White NJ; Chotivanich K
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0148121. PubMed ID: 34978886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation.
    Sindhe KMV; Wu W; Legac J; Zhang YK; Easom EE; Cooper RA; Plattner JJ; Freund YR; DeRisi JL; Rosenthal PJ
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
    Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
    Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of
    Sharma S; Bharti RS; Bhardwaj N; Anvikar AR; Valecha N; Mishra N
    Indian J Med Microbiol; 2017; 35(4):485-490. PubMed ID: 29405138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug susceptibility of
    Tumwebaze PK; Katairo T; Okitwi M; Byaruhanga O; Orena S; Asua V; Duvalsaint M; Legac J; Chelebieva S; Ceja FG; Rasmussen SA; Conrad MD; Nsobya SL; Aydemir O; Bailey JA; Bayles BR; Rosenthal PJ; Cooper RA
    Lancet Microbe; 2021 Sep; 2(9):e441-e449. PubMed ID: 34553183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium falciparum multidrug resistance protein 1 (pfmrp1) gene and its association with in vitro drug susceptibility of parasite isolates from north-east Myanmar.
    Gupta B; Xu S; Wang Z; Sun L; Miao J; Cui L; Yang Z
    J Antimicrob Chemother; 2014 Aug; 69(8):2110-7. PubMed ID: 24855124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Short-Term Storage on
    Okitwi M; Orena S; Thomas K; Tumwebaze PK; Byaruhanga O; Nsobya SL; Conrad MD; Bayles BR; Rosenthal PJ; Cooper RA
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0143721. PubMed ID: 35266828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for Two Distinct Compound Classes.
    Magistrado PA; Corey VC; Lukens AK; LaMonte G; Sasaki E; Meister S; Wree M; Winzeler E; Wirth DF
    ACS Infect Dis; 2016 Nov; 2(11):816-826. PubMed ID: 27933786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia.
    Chaorattanakawee S; Tyner SD; Lon C; Yingyuen K; Ruttvisutinunt W; Sundrakes S; Sai-gnam P; Johnson JD; Walsh DS; Saunders DL; Lanteri CA
    Malar J; 2013 Jul; 12():239. PubMed ID: 23849006
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Somé AF; Conrad MD; Kabré Z; Fofana A; Yerbanga RS; Bazié T; Neya C; Somé M; Kagambega TJ; Legac J; Garg S; Bailey JA; Ouédraogo J-B; Rosenthal PJ; Cooper RA
    Antimicrob Agents Chemother; 2024 Apr; 68(4):e0153423. PubMed ID: 38411062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda.
    Tumwebaze PK; Conrad MD; Okitwi M; Orena S; Byaruhanga O; Katairo T; Legac J; Garg S; Giesbrecht D; Smith SR; Ceja FG; Nsobya SL; Bailey JA; Cooper RA; Rosenthal PJ
    Nat Commun; 2022 Oct; 13(1):6353. PubMed ID: 36289202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.